Adipocyte-derived adipokines such as adiponectin, leptin and resistin, are essential regulators of inflammation and the progression of fibrosis in various chronic liver diseases, and may be used in the treatment of NAFLD [13-16]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.